General Information
Revision date
2019-04-05
Product name
Tolvaptan
CAS No.
150683-30-0
REACH No
is
Icons in SDS
Company Information
company name
TOKU-E Company
e-mail address of the competent person responsible for the Safety Data Sheet
info@toku-e.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361, H362
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
CLP CLASSIFICATION
Reproductive Toxicity (Category 2), H361 (d) (Oral) Effects on or via Lactation, H362 For the full text of the H-Statements mentioned in this section, see Section 16.
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008
Hazard statements
H361 Suspected of damaging fertility or the unborn child H362 May cause harm to breast-fed children
Precautionary statements
P201 Obtain special instructions before use P202 Do not handle until all safety precautions have been read and understood P280 Wear protective gloves/protective clothing/eye protection/face protection. P308+P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container in accordance with governmental regulation P260 Do not breathe dust/fumes/gas/mist/vapors/spray. P263 Avoid contact during pregnancy/while nursing P264 Wash hands/skin thoroughly after handling. P270 Do not eat, drink, or smoke when using this product.
Supplemental label elements
No data available
2.3 Other hazards
No data available
